Bortezomib pinanediol ester
| Post Date: |
Jun 16,2024 |
| Expiry Date: |
Dec 13,2024 |
| Detailed Description: |
Cas No. :205393-22-2
|
| CAS Registry Number: |
|
| Synonyms: |
;Bortezomib pinanediol ester;n-[(1s)-2-[[(1r)-1-[(3as,4s,6s,7ar)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide;n-[(1s)-1-benzyl-2-({(1r)-3-methyl-1-[(1s,2s,6r,8s)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0~2,6~]dec-4-yl]butyl}amino)-2-oxoethyl]-2-pyrazinecarboxamide;bortezomib intermediates iii;Bortezomib Intermediate III; |
| Molecular Formula: |
C29H39BN4O4 |
| Molecular Weight: |
518.46 |
| Molecular Structure: |
|
| Company: |
Qingdao Haohai Anjie Pharmaceutical Technology Co., Ltd.
[ China ]
|
| Contact: |
Colin Chen |
| Tel: |
15050866711 |
| Fax: |
|
| Email: |
contact@zintellec.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
